Charlotte McKee
CMO and Head of R&D · Sionna Therapeutics, Inc.
Individual
- 2026
- Sep 18, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Charlotte McKee files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Peter A. Thompson - $55.67M in SION purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
- Bruce Booth - $18.23M in SION purchases and sales in the last 12 months
- TPG GP A, LLC - $10.00M in SION purchases and sales in the last 12 months
- Michael Cloonan - $4.41M in SION purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Charlotte McKee?
Charlotte McKee is a corporate insider, tracked as CMO and Head of R&D of Sionna Therapeutics, Inc. (SION). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Charlotte McKee submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
